Efficacy and safety of Rivaroxaban compared with Warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban once daily, oral, direct factor Xa inhibition compared with Vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)

Autor:	Halperin, J. L., Hankey, G. J., Wojdyla, D. M., Piccini, J. P., Lokhnygina, Y., Patel, M. R., Breithardt, G., Singer, D. E., Becker, R. C., Hacke, W., Paolini, J. F., Nessel, C. C., Mahaffey, K. W., Califf, R. M., on behalf of the ROCKET AF, FOX K. A. A., Carolei, Antonio, as member of Steering Committee, Investigators
Jazyk:	angličtina
Rok vydání:	2014
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3983::df17305dc2af89dd0497851a5915c52c http://hdl.handle.net/11697/105 Zobrazit plný text záznamu